Get the app
US › Healthcare

Bluejay Diagnostics Inc (BJDX)

US · Healthcare · Medical Devices

$0.84+4.00%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Net profit
$-2.3M
EPS
$-1.12

Key statistics

Market cap
$1.0M
Forward P/E
0.0
P/B
0.11
Book value
$4.75
EPS (TTM)
$-2.25
52-week high
$16.68
52-week low
$0.82
50-day MA
$1.07
200-day MA
$2.40
Beta
0.91

Analyst view

with an average price target of $256.00.

Shareholding

Insiders
2.03%
Institutions
9.79%

Largest institutional holders

FundStake
Sabby Management LLC2.78%
Geode Capital Management, LLC2.72%
Tower Research Capital LLC0.17%
UBS Group AG0.01%
L1 Global Manager Pty Ltd0.01%
Caitong International Asset Management Co., Limited.0.00%
Meteora Capital, LLC0.00%
Bank of America Corp0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Bluejay Diagnostics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.